E. Serra‐Baldrich

3.8k total citations · 1 hit paper
85 papers, 921 citations indexed

About

E. Serra‐Baldrich is a scholar working on Dermatology, Immunology and Allergy and Rheumatology. According to data from OpenAlex, E. Serra‐Baldrich has authored 85 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Dermatology, 31 papers in Immunology and Allergy and 23 papers in Rheumatology. Recurrent topics in E. Serra‐Baldrich's work include Contact Dermatitis and Allergies (43 papers), Dermatology and Skin Diseases (37 papers) and Allergic Rhinitis and Sensitization (27 papers). E. Serra‐Baldrich is often cited by papers focused on Contact Dermatitis and Allergies (43 papers), Dermatology and Skin Diseases (37 papers) and Allergic Rhinitis and Sensitization (27 papers). E. Serra‐Baldrich collaborates with scholars based in Spain, United States and Germany. E. Serra‐Baldrich's co-authors include José G. Camarasa, L. Puig, Ana M. Giménez‐Arnau, M Lluch, Vicente Riambau, J.F. Silvestre, Eduardo Rozas‐Muñoz, Pedro Mercader, A. Guerra‐Tapia and E. González‐Guerra and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Frontiers in Immunology.

In The Last Decade

E. Serra‐Baldrich

77 papers receiving 877 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials

2023 72 citations Andrew Blauvelt, Jacob P. Thyssen et al. British Journal of Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Serra‐Baldrich Spain	18	674	285	117	98	86	85	921
Paolo Lisi Italy	16	623 0.9×	250 0.9×	94 0.8×	155 1.6×	50 0.6×	77	894
B. Santucci Italy	16	435 0.6×	253 0.9×	92 0.8×	143 1.5×	17 0.2×	47	826
Andrew Scheman United States	17	690 1.0×	228 0.8×	48 0.4×	211 2.2×	20 0.2×	63	885
Bernadette Eberlein-König Germany	22	597 0.9×	513 1.8×	54 0.5×	24 0.2×	171 2.0×	41	1.2k
Jack Kao United States	6	852 1.3×	350 1.2×	46 0.4×	26 0.3×	98 1.1×	6	1.3k
Tomoki Fukuyama Japan	20	316 0.5×	230 0.8×	76 0.6×	88 0.9×	205 2.4×	84	1.1k
Anne Herman Belgium	16	588 0.9×	76 0.3×	84 0.7×	226 2.3×	21 0.2×	40	922
Bruce Tate Australia	14	480 0.7×	113 0.4×	23 0.2×	76 0.8×	17 0.2×	24	704
Michael R. Woolhiser United States	20	329 0.5×	234 0.8×	60 0.5×	308 3.1×	211 2.5×	39	1.1k
A. Ferrannini Italy	21	553 0.8×	428 1.5×	488 4.2×	189 1.9×	191 2.2×	71	1.3k

Countries citing papers authored by E. Serra‐Baldrich

Since Specialization

Citations

This map shows the geographic impact of E. Serra‐Baldrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Serra‐Baldrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Serra‐Baldrich more than expected).

Fields of papers citing papers by E. Serra‐Baldrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Serra‐Baldrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Serra‐Baldrich. The network helps show where E. Serra‐Baldrich may publish in the future.

Co-authorship network of co-authors of E. Serra‐Baldrich

This figure shows the co-authorship network connecting the top 25 collaborators of E. Serra‐Baldrich. A scholar is included among the top collaborators of E. Serra‐Baldrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Serra‐Baldrich. E. Serra‐Baldrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ruíz‐Villaverde, Ricardo, et al.. (2025). Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors. International Journal of Dermatology. 65(2). 230–237.

Hita, José Carlos Armario, Manuel Galán‐Gutiérrez, M. Rodríguez‐Serna, et al.. (2025). Real‐World Effectiveness and Safety of Lebrikizumab in Moderate‐to‐Severe Atopic Dermatitis: A Multicenter Study From Spain. International Journal of Dermatology.

Frutos, F.J. Ortiz de, E. Serra‐Baldrich, J.C. Armario-Hita, et al.. (2024). [Translated article] Consensus on the Diagnostic Algorithm for Chronic Nodular Prurigo. Actas Dermo-Sifiliográficas. 115(10). T967–T973. 1 indexed citations

Mercader, Pedro, J.F. Silvestre, F.J. Navarro‐Triviño, et al.. (2024). A re‐assessment of the value of markers of corticosteroid contact allergy in the Spanish baseline series: Clobetasol propionate in the spotlight. Contact Dermatitis. 91(3). 228–236. 1 indexed citations

Bissonnette, Robert, Richard B. Warren, Andreas Pinter, et al.. (2024). Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials. The Lancet. 404(10451). 461–473. 32 indexed citations

Blauvelt, Andrew, Jacob P. Thyssen, Emma Guttman‐Yassky, et al.. (2023). Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials. British Journal of Dermatology. 188(6). 740–748. 72 indexed citations breakdown →

Buades, Juan Manuel, Ignasi Figueras‐Nart, Marián Goicoechea, Rafáel Sánchez, & E. Serra‐Baldrich. (2023). Documento de información y consenso para el manejo diagnóstico y terapéutico del prurito asociado a la enfermedad renal crónica en pacientes en hemodiálisis en España. SHILAP Revista de lepidopterología. 44(4). 465–474. 1 indexed citations

Hita, José Carlos Armario, J.M. Carrascosa, Ángeles Flórez, et al.. (2023). Pruritus and Pain Constitute the Main Negative Impact of Atopic Dermatitis® from the Patient's Perspective: A Systematic Review. Dermatitis. 35(3). 216–234. 1 indexed citations

Figueras‐Nart, Ignasi, Antonio Guilabert, Laia Curto‐Barredo, et al.. (2023). Allergen sensitization stratifies IL-31 production by memory T cells in atopic dermatitis patients. Frontiers in Immunology. 14. 1124018–1124018. 5 indexed citations

10.

Rodríguez, J, Pedro Herranz, Bibiana Pérez, et al.. (2022). Upadacitinib for the Treatment of Atopic Dermatitis in a Spanish Cohort—Real Life: Fifty-Two–Week Follow-up Results. Dermatitis. 33(6S). S124–S127. 8 indexed citations

11.

Silvestre, J.F., Ana M. Giménez‐Arnau, Enrique Gómez de la Fuente, et al.. (2021). Manejo de la urticaria en urgencias: recomendaciones de un grupo multidisciplinar de expertos.. Emergencias. 33(4). 299–308.

12.

Serra‐Baldrich, E., et al.. (2020). Agentes biológicos aprobados y en desarrollo clínico para el tratamiento de la dermatitis atópica. 10–20. 1 indexed citations

13.

Rozas‐Muñoz, Eduardo, et al.. (2017). Dermatitis de contacto alérgica por regiones anatómicas. Claves diagnósticas. Actas Dermo-Sifiliográficas. 109(6). 485–507. 12 indexed citations

14.

Serra‐Baldrich, E., et al.. (2005). Contact dermatitis due to clarifying cream. Contact Dermatitis. 53(3). 174–175. 5 indexed citations

15.

Giménez‐Arnau, Ana M., Elena Giménez‐Arnau, E. Serra‐Baldrich, J.‐P. Lepoittevin, & José G. Camarasa. (2002). Principles and methodology for identification of fragrance allergens in consumer products*. Contact Dermatitis. 47(6). 345–352. 13 indexed citations

16.

Serra‐Baldrich, E., et al.. (2001). Sarcoidosis (II): Inmunopatogénesis. Criterios de actividad. Conclusión. 40(12). 999–1010. 1 indexed citations

17.

Camarasa, José G., et al.. (1997). Contact dermatitis from sodium‐cromoglycate‐containing eyedrops. Contact Dermatitis. 36(3). 160–160. 5 indexed citations

18.

Camarasa, José G., C. Romaguera, E. Serra‐Baldrich, & J. Vilaplana. (1993). Allergic contact dermatitis from Biobans in Spanish metalworkers. Contact Dermatitis. 29(2). 98–98. 10 indexed citations

19.

Camarasa, José G. & E. Serra‐Baldrich. (1992). Allergic contact dermatitis from triphenyl phosphate. Contact Dermatitis. 26(4). 264–265. 56 indexed citations

20.

Camarasa, José G. & E. Serra‐Baldrich. (1990). Palladium Contact Dermatitis. Dermatitis. 1(2). 114–115. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact